Medico-Economic Value

Clinical ValueEconomic Value

Clinical Value

HydroCision devices enable minimally access to procedures traditionally performed through open techniques, thus minimizing surgical morbidity while providing improved clinical outcomes. In addition, the nonthermal nature of fluidjet technology eliminates the risk of thermal damage to surrounding healthy tissue. Each HydroCision device is designed for specific spine and orthopedic applications.

The devices have several clinical advantages.

  • The TenJet tenotomy devices provide a definitive treatment option for patients suffering from chronic tendinopathy.
  • The devices enable tissue selective, non-thermal, cutting and removal of diseased tendons, thereby enabling the initiation of the healing process.
  • Early results demonstrate an average of 85% postoperative improvement of pain and function scores.

  • A precise volume of disc material is removed in two to four minutes regardless of the patient’s age or disc pathology.
  • 4 mm PercResector and MicroResector access cannula spares the outer annulus by allowing the annular fibers to shrink back into place, potentially decreasing the rate of disc herniations.

Economic Value

The impact of minimally invasive techniques in reducing overall health-care costs by minimizing risk of complications associated with open techniques has been studied and documented in multiple fields.

Three examples of these medico-economic advantages follow.

  • TenJet for tenotomy procedures offers significant savings to ASCs or outpatient surgery centers in terms of resource utilization. The sterile procedure kit contains the TenJet handpiece as well as many of the disposable supplies needed for the procedure.
  • In addition, health-care systems experience significant savings due to resolution of pain in chronically symptomatic patients and associated reduction in payments for office visits and diagnostic or treatment procedures.

  • Compared to traditional manual methods of performing surgical discectomies, SpineJet’s MicroResector technology has demonstrated an average cost savings of $2,114 per patient. This is mainly due to a reduction in rates of reherniation, recurrent radicular pain in the absence of reherniation, and reoperation.

Skip to toolbar